During the past decade, Asklepios Klinik Langen conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asklepios Klinik Langen" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Charite University, Berlin, Germany" with 1 trials sponsored, "Otto-von-Guericke University Magdeburg" with 1 trials sponsored, "Resverlogix Corp" with 1 trials sponsored and "University of Leipzig" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Klinik Langen" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator, "German Research Foundation" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator and "Medidata Solutions" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Asklepios Klinik Langen" are "Heart Failure" (3 trials), "Atrial Fibrillation" (1 trials), "Chronic Heart Failure" (1 trials), "Coronary Artery Disease" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Asklepios Klinik Langen" in a lesser frequency.

Most popular intervention types in "Asklepios Klinik Langen" are "Drug" (5 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (3 trials), "Placebo" (3 trials), "Apabetalone" (1 trials), "Aspirin" (1 trials) and "Atorvastatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asklepios Klinik Langen" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Asklepios Klinik Langen". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Asklepios Klinik Langen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Asklepios Klinik Langen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".